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ABSTRACT OF THE THESIS 
 
 
Investigation of ABBA prenyltransferases in marine Streptomyces: enzymes involved in the 
biosynthesis of meroterpenoid antibiotics 
 
by 
 
Darlene HP Nguyen 
 
Masters of Science in Chemistry 
 
University of California San Diego, 2018 
 
Professor Bradley S. Moore, Chair 
 
 
Bacterial meroterpenoids are hybrid natural products that partially originate from 
polyketide synthesis and become highly specialized upon prenylation with terpenoid products. 
The prenylation event is catalyzed by prenyltransferases (PTases), a class of enzymes that are 
essential to the biosynthesis of terpenoid compounds such as the napyradiomycins, merochlorins, 
and marinones. Biochemical assays confirm the prenylation activity of prenyltransferases NapT8 
xii 
 
and NapT9 from the napyradiomycin pathway and Mcl23 from the merochlorin pathway in 
Streptomyces. The study of these PTases was extended to further investigate their structure and 
specifically focused on studying the substrate promiscuity of NapT8. Results confirmed that 
NapT8 is highly specific for its prenyl substrate in physiological assay conditions and R58 is 
speculated to be one of the active site residues responsible for this specificity. Additionally, 
NapT8 activity has been expanded in the presence of a reducing agent, seemingly producing 
dechlorinated side products that have not been observed before. 
In a parallel study, the activity and specificity of related prenyltransferases CnqP3 and 
CnqP4 derived from marine Streptomyces sp. CNQ-509 were investigated in the context of a 
putative neomarinone/marinone gene cluster. Despite confirmation of their prenylation 
capabilities, results show that CnqP3 and CnqP4 did not produce any observable products with 
the proposed starter units of the neomarinone pathway or the marinone pathway.  
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INTRODUCTION 
Natural products chemistry 
In the broadest sense, natural products are chemical compounds produced by living organisms 
ranging from small microbes to large animals. Natural products are generally derived from the 
secondary metabolic pathways of living organisms. Primary metabolites are compounds directly 
involved in the growth, development, and survival of the organisms. Amino acids, sugars, 
nucleic acids are primary metabolites because they are essential for creating proteins, energy, 
and DNA, all of which are essential to sustaining life. Secondary metabolites are compounds that 
are not necessarily essential for survival, but provide with at least one terpene moiety the 
producer organism an evolutionary advantage. For example, some secondary metabolites can be 
cytotoxic to ward off predators or competitors. Because of their diversity and potency, bioactive 
secondary metabolites hold great potential as a resource for therapeutic drug discovery. 
 
Figure 1. Classes of natural products. The polyketides, alkaloids, NRPs, and terpenoids are distinct classes based on 
their biosynthetic pathways.  
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Natural products are very diverse and complex in their chemical compositions, but they can 
generally be sorted by their structural classes including the alkaloids, nonribosomal peptides 
(NRPs), polyketides, ribosomal natural products (RiPPs), and terpenoids (Figure 1). Bacteria 
have proven to be prolific producers of potent antibiotics. For example, streptomycin, 
chloramphenicol, and tetracycline, are produced by soil bacteria [21]. Similarly, many other 
genera of bacteria are known to produce diverse compounds with anti-microbial properties. 
Actinobacteria are the phylum of Gram-positive bacteria that have historically been a leading 
source for natural product discovery and have been reported to be rich in NRPs, polyketide, and 
terpenoid chemistry. 
 
Figure 2. Hybrid natural products. The terpene units are highlighted in red. 
Some natural products exist as hybrids of these structural classes and often they are more 
bioactive than their precursor units (Figure 2). For example, the napyradiomycins and 
merochlorins are potent antibiotics while tetrahydroxynaphthalene, the precursor to these 
molecules, is not bioactive. 
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Marine actinomycete-derived meroterpenoids 
Several highly specialized hybrid polyketide-terpene structures have been isolated from marine 
actinomycetes. These hybrid structures are characterized by having a polyketide scaffold adorned 
with at least terpene moiety, with the attachment site bearing a carbon, nitrogen, or oxygen atom 
and are collectively referred to as meroterpenoids (Figure 3).  
 
Figure 3.  Examples of isolated the PKS-terpenoid hybrid class of meroterpenoids: napyradiomycins, merochlorins, 
and marinones. The PKS core structure is shown in black whereas the terpene moieties are highlighted in color 
depending on their chain length. The pathway to the marinone and neomarinone products is hypothetical and is 
denoted by a dashed arrow 
The hybridization of a PKS product and a terpene product allows for modularity which leads to a 
diverse array of natural products with specialized chemical and biological functions. 
Furthermore, many of the meroterpenoids are halogenated, increasing their chemical complexity. 
In many cases, addition of a terpene moiety to a PKS product increases the bioactivity of the 
non-prenylated precursor, often by increasing affinity for biological membranes and interactions 
with cellular targets [1].  
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Polyketide biosynthesis 
Polyketides are synthesized by polyketide synthases (PKS) and are broadly divided into three 
classes: type I polyketides (primarily macrolides), type II polyketides (often aromatic molecules 
predominantly produced by bacteria, especially actinomycetes), and type III polyketides (often 
small aromatic molecules produced by plants, fungi, and bacteria). This study focused on the 
bacterial type III PKS product 1,3,6,8-tetrahydroxynaphthalene (THN). Polyketides are 
biosynthesized through the decarboxylative condensation of malonyl-CoA derived extender units 
in a similar process to fatty acid synthesis (a Claisen condensation). THN is synthesized by five 
iterative Claisen condensations of coenzyme A linked malonyl units (malonyl-CoA) (Figure 4). 
The linear pentaketide folds into a pentaketide ring by an intramolecular Claisen condensation 
and then into the fused 6-membered rings by subsequent aldol condensation. Finally, the 
carbonyl groups tautomerize to create THN [2]. 
 
Figure 4. Mechanism of THN biosynthesis by a type III PKS 1,3,6,8-tetrahydroxynaphthalene synthase. Coenzyme 
A (CoA) is a carrier protein that shuttles malonate to the PKS module(s). Five iterative condensations of Malonyl-
CoA form a linear pentaketide structure. The pentaketide forms a ring via an intramolecular Claisen condensation 
and several rounds of aldol condensations produce the final THN structure. 
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Terpene biosynthesis 
Terpenes are a large group of natural products that are diverse in length and composition. They 
are biosynthesized using isoprenoid precursors of different lengths that are subsequently 
modified, most commonly through cyclization. The precursors are produced by the condensation 
of several 5-carbon isoprene units with a basic molecular formula of (C₅H₈)n where n is the 
number of linked isoprene units (Figure 3). The isoprenoids are categorized into classes 
according to the number of isoprene units forming their parent terpene scaffolds: hemiterpenoids 
(1-unit, C5), monoterpenoids (2-units, C10), sesquiterpenoids (3-units, C15), diterpenoids (4-
units, C20).  
Isoprene units are derived from its activated forms isopentenyl pyrophosphate (IPP) and its 
isomer dimethylallyl pyrophosphate (DMAPP) which are essentially an isoprene unit with a 
diphosphate group on the terminal carbon (Figure 3). IPP and DMAPP are generated via an  
isoprenoid biosynthetic pathway, also known as the mevalonate (MVA) pathway (Figure 5a), but 
they can also be synthesized by the non-mevalonate (MEP) pathway (Figure 5b). 
 
 
Figure 5. Biosynthesis of terpene and terpenoid structures. (a) DMAPP/IPP can be produced from acetyl-CoA from 
the mevalonate pathway (MVA). (b) DMAPP/IPP can be produced from pyruvic acid and D-glyceraldehyde-3-
phosphate from the mevalonate-independent pathway (MEP). (c) GPP is produced by a head-to-tail condensation of 
DMAPP and IPP. FPP is produced by an additional condensation of IPP to GPP in a head-to-tail orientation. 
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Actinomycetes often use both pathways to synthesize IPP. The MEP pathway is active during 
early stages of growth where primary metabolites are produced, whereas the MVA pathway is 
active during the later stages of fermentation where secondary metabolites are produced [20]. 
Actinomycetes are known to be abundant producers of secondary metabolites due to its 
utilization of the MVA pathway for meroterpenoid production [20]. Longer chained isoprenoids 
by head-to-tail condensations of DMAPP and IPP, most notably geranyl pyrophosphate (GPP) 
and farnesyl pyrophosphate (FPP) are often used by PTases to generate meroterpenoids (Figure 
5) [1]. DMAPP, GPP, and FPP are the reported isoprenoid substrates for Streptomyces PTases. 
ABBA Type Prenyltransferases 
In meroterpenoid biosynthesis, a series of conserved prenyltransferases ae responsible for 
installing isoprenoids onto the polyketide scaffold. These aromatic prenyl transferases are often 
called ABBA PTases which are named for the array of their secondary structure – a repeated α-
β-β-α motif which is a characteristic fold that consists of a central barrel (PT barrel) with ten 
anti-parallel β-strands surrounded by α-helices [1,4] (Figure 6). ABBA PTases are exclusively 
found in secondary metabolism but are diverse enough to be categorized as two distinct families 
based on their substrate specificity – the phenol/phenazine prenyltransferases and the indole 
prenyltransferases. In this study, we focus on phenol prenyltransferases. 
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Figure 6. Example of ABBA PTase structure. Crystal structure shown here is for 1ZB6 by the Noel group [10]. 
Shown is the side profile view(left). Also shown is the view of the catalytic cavity (right). The key catalytic residues 
are shown above. 
These PTases catalyze an aromatic prenylation in which a carbon-carbon bond is formed 
between the aromatic carbon of the PKS product and the electrophilic carbon of the activated 
isoprenoid product, similar to a Friedel-Crafts alkylation (Figure 7). In meroterpenoid 
biosynthesis, a naphthalene derivative is the aromatic nucleophilic substrate and the isoprenoid is 
the electrophilic substrate. ABBA enzymes catalyze elimination of the pyrophosphate from the 
isoprenoid, generating a carbocation center on the prenyl group. Due to the placement of the 
hydroxyl groups, the C-2 and C-4 positions are electronically rich. The ring can dearomatize to 
form a carbon-carbon bond with the prenyl group. Next, the ring tautomerizes to restore 
aromaticity. 
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Figure 7. General mechanism of prenylation by the ABBA PTase. (1) Pyrophosphate group leaves, generating the 
carbocation. (2) The ring de-aromatizes at the nucleophilic carbon on THN forming a carbon-carbon bond with the 
prenyl group (3) the ring re-aromatizes to restore aromaticity at the prenylated carbon. The same mechanism can 
occur at the C-4 carbon. 
Previous biochemical investigation of characterized PTases NapT8, NapT9, Mcl23 
Several ABBA PTases have been characterized in the Moore Lab, notably NapT8 and NapT9 
from the napyradiomycin pathway and Mcl23 from the merochlorin pathway [3, 7, 23]. These 
three enzymes are reported to have remarkable substrate selectivity for their native prenyl group 
[1]. NapT8 only accepts DMAPP and NapT9 only accepts GPP as their prenyl donors. Mcl23 
selectively prenylates with an isosesquilavandulyl (branched FPP) group and has also been the 
first reported enzyme to prenylate with a branched prenyl donor [7]. Additionally, these three 
enzymes prenylate at a specific carbon with incredible selectivity. NapT9 and Mcl23 specifically 
prenylates at the C-4 position while NapT8 prenylates at the C-2 position [3] (Figure 8). One aim 
of this project was to determine the origins of this observed substrate specificity. 
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Figure 8. Prenylation reactions for NapT8, NapT9, NapH3 and Mcl23. NapT8 catalyzes a prenylation at the C2 
position. NapT9 and Mcl23 catalyzes prenylation at the C4 position.  
The reaction that NapT8 catalyzes is especially unusual in that it attaches a dimethylallyl moiety 
to a carbon center that is less activated due to the chlorinated substituent on the same carbon to 
generate a prenylated naphthalene-derived product (Figure 8). This prenylated product quickly 
undergoes a rearrangement catalyzed by the enzyme NapH3 where the geranyl moiety on the C-4 
shifts to the C-2 position. This rearrangement of a prenyl group represents a very novel 1,2-shift 
of a large bulky moiety (Figure 8). Interestingly, this shift happens directly after NapT8 
prenylates at the C-2 position. This suggests that the NapT8 prenylation could potentially prime 
the C-3 position for the prenyl shift from the C-4 position. Because of the unprecedented 
prenylation activity of NapT8, its substrate specificity merits further investigation.  
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Biochemical Investigation of Streptomyces sp. CNQ-509 PTases CnqP3 and CnqP4 
Streptomyces sp. CNQ-509 makes both marinone and neomarinone metabolites but the precise 
gene cluster has yet to be identified. Based on the reported spatial organization of biosynthetic 
gene clusters identified for meroterpenoid natural products in other actinomycetes, we propose 
that the colocalization of THN synthases and ABBA prenyltransferases in the putative gene 
cluster (Figure 9) might indicate the gene cluster for these molecules. A previous study reported 
that several putative ABBA prenyltransferases Streptomyces sp. CNQ-509 are capable of 
prenylation naphthalene analogs with DMAPP and GPP [4]. Of these putative PTases, CnqP3 
and CnqP4 seem to be the most interesting based on the location of their gene sequences in the 
putative marinone gene cluster (Figure 9). The cnqP4 gene (Figure 9a) is located upstream from 
a THN synthase. Similarly, the cnqP3 gene (Figure 9b) is located upstream from another THN 
synthase. Based on the spatial organization of these genes, it has been hypothesized that CnqP3 
and CnqP4 can potentially prenylate THN.  
 
Figure 9. Putative marinone biosynthetic gene cluster from Streptomyces sp CNQ-509. (A) gene for CnqP4 (B) gene 
for CnqP3. Figure adapted from analysis done by Dr. Zachary Miles. 
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Previous studies have confirmed that CnqP3 and CnqP4 are capable of prenylation and are even 
capable of substrate promiscuity [4]. Although these two proteins have been heterologously 
expressed and characterized in vitro, their native specificity and site of prenylation is largely 
unknown. Bioinformatic analysis determined that NapT8, NapT9, and Mcl23 show sequence 
similarity to CnqP3 and CnqP4 which may give some clues about their activity.  
In the napyradiomycins, prenylation occurs at a nucleophilic C-4 position by ABBA PTase 
NapT9 [23] and the prenyl group later rearranges to the C-3 position by the enzyme NapH3, 
generating a C-3 prenylated product. In the case of the marinones and neomarinones, the final 
product is also prenylated at the C-3 position. This poses the question that if CnqP3 and CnqP4 
show structural similarity to ABBA Ptases that have known prenylation activities at the C-2 and 
C-4 position, that perhaps CnqP3 and CnqP4 could be investigated for similar activity. The 
hypothetical biosynthetic scheme is shown in Figure 10. However, neomarinone is prenylated at 
the C-2 position but by a reverse prenylation. Given the prenylation pattern of napyradiomycins 
where there is a rearrangement of the prenyl group, we propose that a similar rearrangement 
could potentially occur in the neomarinone pathway. This suggests that this prenylation could 
result from a reverse prenyltransferase or potentially through a Cope rearrangement of a C-4 
prenylated product. 
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Figure 10. Proposed mechanism for CnqP3 or CnqP4. (a) Addition to C-4 position and a downstream α-
hydroxyketone arrangement to the C-3 position can lead to the marinone pathway. (b) A Cope rearrangement from 
the initial C-4 prenylation to the C-2 position can lead to the neomarinone pathway.  
To determine whether PTases CnqP3 and CnqP4 are involved in the debromomarinone, 
marinone, or neomarinone pathway, the bioactivities of CnqP3 and CnqP4 with isoprenoid 
substrate farnesyl pyrophosphate (FPP) and polyketide substrate 1,3,6,8-tetrahydroxynaphthalene 
(THN) were investigated.  
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PROJECT MOTIVATION  
The motivation for this study is to explore ABBA prenyltransferases to understand their substrate 
specificities and the types of chemistry they are capable of catalyzing. The first aim of this 
project is to investigate the substrate specificity of NapT8 which is an ABBA PTase that is 
involved in a known biosynthetic pathway. With this knowledge, we sought to increase the 
modularity of napyradiomycin synthesis. The second aim is to investigate the chemical capacity 
PTases in Streptomyces sp. CNQ-509 that are implicated in the biosynthesis of marinone or 
neomarinone and CnqP4 to determine if they are capable of generating the hypothesized 
precursors of the marinone or neomarinone pathway. 
Investigation of the substrate specificity of NapT8 
The goal is to investigate the substrate specificity of NapT8 by (i) determining how the 
substrates bind in the active site, (ii) relaxing the specificity by generating a rationally-designed 
mutant, and (iii) using synthetic analogs of the native prenyl substrate using novel 
pyrophosphates. NapT8 plays a crucial role in initiating the biosynthetic intermediate for 
napyradiomycin A1 production. As such, it would be interesting to modify NapT8 to accept 
different substrates in order to produce novel napyradiomycin analogs.  
Investigation of roles of putative ABBA PTases CnqP3 and CnqP4.  
The goal is to determine the native function of CnqP3 and CnqP4. These putative ABBA PTases 
have been reported to catalyze prenylation of naphthalene analogs, but it is unclear what their 
native functions are because they seem to exhibit substrate promiscuity [4]. The objective is to 
investigate the capability of CnqP3 and CnqP4 to prenylate THN which could potentially be the 
precursor to feed into the marinone or neomarinone pathway. 
14 
 
MATERIALS AND METHODS 
General procedure for cloning, overexpression, and purification of recombinant E. coli 
BL21 
The DNA constructs were cloned into E. coli BL21 (DE3) Gold and the transformants were 
plated on Lysogeny Broth (LB) agar plates with 50 μg/mL kanamycin to grow overnight at 37 °C 
for 16 h. The next day, colonies were picked, inoculated into 10 mL LB in 50 μg/mL kanamycin, 
grown overnight for 16 h with shaking. For protein overproduction, 10 mL of preculture was 
used to inoculate a 1 L of Terrific Broth (TB) media with 50 μM kanamycin. The culture was 
incubated at 37 °C and shaking at 220 rpm until OD600 reached 0.7. Then the incubator was 
lowered to 18 °C. After 1 h, the culture was induced with isopropyl β-d-1-thiogalactopyranoside 
(IPTG) to a final concentration of 100 μM. The culture was then grown overnight for 16 h before 
the cells were harvested (10 min, 4 °C, 13,000 x g). The cell pellets were then resuspended in 
fresh lysis buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 10% (v/v) glycerol, 20 mM 
imidazole, 10 mM β-mercaptoethanol). The cell slurry was treated with a Sonic Dismembrator 
(Fisher Scientific, Model 100) at 4 °C to rupture the cells. The lysate was centrifuged (15000 x g, 
30 min, 4°C). The supernatant was purified using a Nickel column (GE Healthcare) according to 
the manufacturer’s instruction. The sample was eluted using a linear gradient of 20 to 250 mM 
imidazole (in 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 10% (v/v) glycerol, 10 mM β-
mercaptoethanol) within 50 min.  
The UV traces for protein purification and the SDS-PAGE gel images are detailed in the 
appendix section A1. 
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I. Investigating NapT8 Substrate Specificity 
Purification of NapT8 
NapT8 gene was cloned into pET28a with an N-terminal His-tag. Transformation, 
overexpression, and purification of NapT8 was done using the general purification procedure. 
The Ni-purified protein fraction was dialyzed with thrombin overnight to cleave the poly-
histidine tag. The dialyzed sample was purified using size exclusion chromatography (Hiload 
16/60 Superdex 75 prep grade) and eluted with gel filtration buffer 20 mM HEPES, 300 mM 
KCl, 10% (v/v) glycerol, and 2 mM 1,4-dithiothreitol (DTT).   
Crystallization Screening of NapT8, NapT9, Mcl23 
Crystallization trials were set up using 6 sets of commercial crystallization buffers: Index 1-48, 
Index 49-96, Rigaku Wizard, Natrix, Crystal Screen, Crystal Screen 2. The enzymes were 
assayed at a final concentration of 8 mg/mL enzyme, and 1 mM DTT and brought up to volume 
with gel filtration buffer. In another set of crystallization trials, a final concentration of 1 mM 
DMASPP (Appendix A2) was added to the NapT8 protein mix and 1 mM GSPP (Appendix A2) 
was added to NapT9 protein mix. The crystal trays were incubated at 4°C overnight and screened 
for crystals at 16h, 48h, and 1 week.  
Activity Assays of NapT8 
The reactions for NapT8 and R58T were incubated overnight (16 h) in 50 mM HEPES pH 8.0, 
100 mM KCl, 5% glycerol, 10 mM MgCl2, 1 μL of inorganic pyrophosphatase (PPase,), and 5 
mM DTT at which point argon gas was bubbled through the solution. Then, 5 mM aromatic 
substrate, 5.5 mM isoprenoid substrate, and 50 μM enzyme was added to a total reaction volume 
of 500 μL at room temperature. After incubation, 50 μL of the reaction was quenched with 50 μL 
16 
 
of HPLC grade methanol and then centrifuged (13000 x g, 21°C, 2 min). The supernatant was 
used for analysis via liquid chromatography coupled mass spectrometry (LC-MS). 
Computational modeling of NapT8 
I-TASSER (Iterative Threading ASSEmbly Refinement) is a computational model method used 
to generate protein model predictions from the amino acid sequences [13, 14, 15, 16]. The I-
TASSER server generated a protein model prediction for NapT8 and the models was 
subsequently used in the homology model. The Dali server is a network service for comparing 
protein structures in 3D. The I-TASSER model were submitted to the Dali server where the 
structures are compared against solved protein structures in the Protein Data Bank (PDB). 
Protein 1ZB6 was selected for the homology model because its crystal structure was solved with 
its active site bound to GSPP. UCSF Chimera software was used to visualize the homology 
model [17]. 
Generating mutants for NapT8  
Mutations of NapT8 were generated using a homology model with izb6. Four mutants of NapT8 
were generated for the active site specificity study. 1) Threonine 60 (T60) was mutated to an 
alanine. The forward primer used: 5'-CTCGACTGCCGTTTCGCGGCGCTGCC-3'. The reverse 
primer used 5'-GGCAGCGCCGCGAAACGGCAGTCGAG-3'. 2) Threonine 60 (T60) was 
mutated to a glycine. The forward primer used: 5'-CGACTGCCGTTTCGGGGCGCTGCCGGC-
3'. The reverse primer used: 5'-GCCGGCAGCGCCCCGAAACGGCAGTCG-3'.  
3) Arginine 58 was mutated to serine. Forward primer:  5'-
GGACCTCGACTGCAGTTTCACGGCGCT-3'. Reverse primer: 5'-
AGCGCCGTGAAACTGCAGTCGAGGTCC-3'. 4) The alpha helix from Threonine 60 to 
(amino acid) 67 with amino acid sequence (8 letter sequence) was mutated to (8 letter sequence). 
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Forward primer: 5'-
TCCGTTCCGACCTCGCATGGTGACCCGTACCGCTACGCGGTGTCGAAGG-3’. Reverse 
primer: 5'-GTCACCATGCGAGGTCGGAACGGAGAAACGGCAGTCGAGGTCCTTGCTG-
3’. Gibson Assembly was used to insert the mutated NapT8 gene into expression vector pET28a. 
Forward primer: 5’-GGTGCCGCGCGGCAGCCATATGACTGACACAGGCATGGA-3’. 
Reverse primer: 5’- GCTCGAGTGCGGCCGCAAGCTTTCAGCTGCCGGCGCCCGCCG -3’. 
The plasmid was transformed into chemically competent Top10 cells for DNA expression and 
chemically competent BL21 cells for protein expression. The mutants were expressed and 
purified in the same conditions above. 
Synthesis of unnatural prenyl groups 
The four synthetic prenyl groups analogs were synthesized by Dr. Shaun McKinnie using a 
similar protocol to that of the FPP synthesis (see below).  
Analysis by LC-MS 
The samples were applied to LC-coupled mass spectrometry (LC-MS) using a Luna 5u C18(2) 
100A column (100 × 4.6 mm) and an ion trap mass spectrometer (amaZon SL, Bruker; Agilent 
1200 series, Agilent Technology). Chromatography was carried out at a flow rate of 0.75 
mL/min with a linear gradient from 10 to 100% of solvent B in 15 min (solvent A: water with 
0.1% formic acid; solvent B: acetonitrile with 0.1% (v/v) formic acid).  
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II. Investigation of putative ABBA PTases in Streptomyces sp. CNQ-509 
Purification of CnqP3 and CnqP4 
To investigate the catalytic capacity of CnqP3 and CnqP4 in vitro, the enzymes were expressed 
and purified from recombinant E. coli. The putative ABBA prenyltransferases genes 
AA958_24325 (CnqP3) and AA958_24270 (CnqP4) were amplified by PCR from genomic 
DNA and cloned into the expression vector pET28a by Dr. Zachary Miles. The corresponding 
proteins were transformed into chemically competent BL21 cells and expressed as N-terminally 
His6-tagged proteins. The proteins were initially purified by Ni
2+-affinity chromatography in the 
same preparation as the purification of NapT8, NapT9, and Mcl23 as described above. The 
Nickel purified fraction was subsequently purified by a PD-10 column and eluted with a buffer 
of 10 mM Tris-HCl pH 8.0, 10% v/v glycerol, and 2 mM DTT. Both enzymes were readily 
expressed in soluble form. SDS-PAGE gel electrophoresis of all expressed enzymes in 
comparison with a molecular weight standard suggests the expression of desired proteins. As 
reported in a previous study [4] the His6-tag does usually not influence the activity of ABBA 
prenyltransferases and so the unmodified proteins were used in the assays.  
Synthesis of enzymatic substrates 
Chemicals and molecular biological agents were purchased from standard commercial sources 
with the exception of dimethylallyl pyrophosphate (DMAPP), geranyl diphosphate (GPP) and 
farnesyl diphosphate (FPP), and 1,3,6,8-tetrahydroxy-naphthalene (THN) which were 
synthesized by Dr. Shaun McKinnie and the synthetic racemic T8 substrate was obtained from 
collaborator Prof. Jonathan George (University of Adelaide). A fresh sample of FPP was 
synthesized for this study following the literature procedures [22]. 
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Synthesis of FPP 
FPP was synthesized according to published procedure by A.B. Woodside, et al with an 85.5% 
yield. The FPP was isolated as a tris-ammonium salt. The structure was verified by NMR.  
 
Scheme 1. Synthesis of FPP 
Phosphorus tribromide (PBr3, 0.34 mmol) was added to farnesol (0.54 mmol) in 10 mL of 
anhydrous THF at 0°C (step 1, scheme 1). The mixture was stirred for 45 min over a ice cold 
water bath. Thin layer chromatography was used to confirm consumption of farnesol. The 
reaction was quenched with ice cold deionized water. The organic material was extracted using 
hexanes (3x 10 mL). The organic layers were pooled, dried over magnesium sulfate, filtered, and 
concentrated on a rotary evaporator. This crude residue was resuspended in 10mL of acetonitrile. 
Tris(tetrabutylammonium) hydrogen pyrophosphate (1.10 mmol) was added (step 2 Scheme 1) to 
the mixture. The reaction was left to stir overnight at room temperature. The reaction was 
concentrated on a rotary evaporator and resuspended in 20 mL of ion-exchange buffer (25 mM 
NH4HCO3, 2% isopropanol). This mixture was loaded onto a DOWEX AG-50 W-X8 NH4
+ form 
resin column that had been equilibrated with 3 column volumes of fresh ion exchange buffer. 
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The product was eluted with 2 column volumes of ion exchange buffer. The fraction was flash 
frozen on dry ice and lyophilized overnight.  
The solid was resuspended in 1 mL of 50 mM NH4HCO3 and 4 mL of 1:1 (v/v) mixture of 
acetonitrile and isopropanol and vortexed. Then the mixture was centrifuged (2000 rpm, 5 min, 
room temperature). The supernatant was transferred to a volumetric flask. This procedure was 
repeated four more times. The supernatants were pooled and then concentrated on a rotary 
evaporator. The extract was then purified by cellulose column chromatography. The product was 
eluted using a 1:2:1 ratio of water: acetonitrile: isopropanol by volume with a final concentration 
of 50 mM NH4HCO3. The fractions were pooled and concentrated using a rotary evaporator. The 
purified extract was resuspended in water and lyophilized overnight.  
Activity Assays of CnqP3, and CnqP4 
The reaction mixtures for CnqP3 and CnqP4 were incubated overnight (16h) under argon gas in 
50 mM Tris-HCl pH 8.75, 5 mM MgCl2, 10 mM ascorbic acid, 200 mM NaCl, 1 mM isoprenoid 
substrate, 2 mM aromatic substrate and 10 μM enzyme to a total reaction volume of 100 μL at 
room temperature [4]. After incubation, the reaction was quenched with 100 μL of HPLC grade 
methanol and then centrifuged (13000 x g, 21 °C, 2 min). The supernatant was used for analysis 
via liquid chromatography coupled mass spectrometry (LC-MS).  
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RESULTS and DISCUSSION 
Investigating NapT8 Substrate Specificity 
1. Crystallization trials with NapT8, NapT9, Mcl23 
In an effort to characterize the active site of the meroterpenoid prenyltransferases and determine 
the details of substrate binding, we first sought to obtain a protein crystal structure. 
Unfortunately, crystallization trials with NapT8, NapT9, and Mcl23 were unsuccessful. In 
general, the proteins precipitated in many of the crystallization conditions or remained soluble in 
others. Attempts were made to crystallize them with analogs of their native substrate in order to 
“lock” them in a stable conformation. NapT8 was incubated with dimethylallyl 
thiolodiphosphate (DMASPP), an analog of the native substrate DMAPP in which the non-
bridging oxygen has been replaced by sulfur. NapT9 was incubated with geranyl 
thiolodiphosphate (GSPP), an analog of NapT9 native substrate GPP in which the non-bridging 
oxygen has been replaced by sulfur, and its native aromatic substrate. Attempts to crystallize 
NapT8 and NapT9 in these conditions also proved unsuccessful. It has previously been reported 
that protein methylation can potentially stabilize protein conformation by stabilizing surface 
charges by methylating lysine residues on the surface of the protein [11]. Attempts to crystallize 
methylated NapT8 and NapT9 were also unsuccessful. These results support that NapT8, NapT9, 
and Mcl23 are difficult to crystallize under conditions tested here.  
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Figure 11. Homology model of NapT8 and 1ZB6. The turquoise residues belong to 1zb6. The magenta residues 
belong to the NapT8 model. The overall alignment of NapT8 and 1ZB6 is shown on the left. The alignment of active 
sites are shown on the right. The residues shown here are within 4A° of GPP.  
2. Generating mutants for NapT8 using a homology model 
In the absence of crystal structures of NapT8, NapT9, and Mcl 23, predictions can be made about 
their structure using homology models. Given the unique prenylation activity of NapT8 
compared to that of the other PTases, the rest of the project focused on NapT8. A homology 
model was made to investigate NapT8 substrate specificity using the I-TASSER online server. 
Using the model, we focused on the residues that could be important for substrate selectivity. 
Previous investigation of NapT8 substrate specificity showed that NapT8 only accepts DMAPP 
as a prenyl donor and not the longer prenyl donor GPP [3]. To investigate this specificity, a 
computational model was used to visualize the active site by structural alignment to NphB, an 
ABBA PTase that has been computationally determined to be homologous to NapT8 (Figure 6, 
left). NphB is a prenyltransferase that attaches GPP to 1,6-DHN [22]. The overlap of α-helices 
and β-sheets supports that NapT8 has high homology to 1ZB6 with respect to secondary and 
tertiary structure (Figure 11). Since the crystal structure for ABBA PTase 1ZB6 has been solved 
with GSPP (a GPP analog that is inactive) bound in the active site (Figure 6, right), its active site 
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can provide clues on how NapT8 might bind DMAPP [10]. Upon alignment of the active sites of 
NapT8 and 1ZB6, the ABBA PTase 1ZB6 bears a Ser64 in the same space that NapT8 has an 
Arg58 which suggests that the R58 on NapT8 seems to sterically hinder GPP from being 
accepted into the catalytic site of NapT8 (Figure 6, right). To test this hypothesis, the R58 in 
NapT8 was mutated to a S58 using site-directed mutagenesis to produce an R58S NapT8 mutant.  
 
Figure 12. A Comparison between the NapT8 function and enzyme 1ZB6 function. 
Activity Assays with NapT8 mutant R58S 
As expected, NapT8 generated the prenylated product with DMAPP (Figure 12, top left) but not 
GPP (Figure 12, bottom left) which is consistent with what has been previously reported [3]. 
However, even with the mutation of the large arginine in the active site, the R58S mutant also 
did not exhibit activity when incubated with GPP (Figure 12, top right). Additionally, this R58S 
mutant lost all activity with DMAPP, the native substrate (Figure 12, bottom right). This 
suggests that R58 is important for activity, but does appear to select for the length of the prenyl 
donor. 
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Figure 13. Activity assays of NapT8 and R58S mutant with the native substrate DMAPP (top row) and with non-
native substrate GPP (bottom row). The peak at RT= 18-19min has an m/z=378 which corresponds to the NapT8 
native aromatic substrate (Figure 15, 1). The peak at RT=22-23 min has an m/z=445 which corresponds to the 
NapT8 native product. 
Unexpectedly, results from the NapT8 assay with DMAPP deviated slightly from results in 
literature (Figure 13) [3]. The results gathered here show a significant reduction in product 
formation when compared to the results that were previously reported. Additionally, a peak at 
m/z = 411 was observed in these assays that were not present in the previously reported assays. It 
was determined that the presence of DTT altered the known NapT8 function and induced a 
previously unreported activity.  
3. Biochemical investigation of NapT8 
In this study, the NapT8 preparation was slightly modified from the preparation previously 
reported to optimize protein purity. NapT8 was purified in the presence of reducing agents to 
prevent aggregation during protein purification. β-mercaptoethanol was added to the elution 
buffers in nickel purification and DTT was added to the elution buffer during size-exclusion 
chromatography. This suggests that NapT8 activity generates side products in the presence of 
reducing agent.  
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To test this hypothesis, the native NapT8 reaction was incubated in 0 mM DTT, 0.5 mM DTT, 
and 5 mM DTT. It was observed that NapT8 native activity is significantly diminished in the 
presence of DTT (Figure 14). Additionally, the NapT8 reactions with DTT seems to generate 
side products. When the NapT8 assay is incubated with DMAPP in DTT, several peaks with m/z 
values of 411 and 409 were observed, masses of which are consistent with masses of the 
proposed dechlorinated NapT8 products 3 and 4 (Figure 15). This suggests that DTT causes 
NapT8 to perform unexpected functions of which are predicted to be dechlorination of the 
aromatic substrate.  
 
Figure 14. NapT8 assays incubated in different concentrations of DTT: 0 mM DTT (top), 0.5 mM DTT (middle), 5 
mM DTT (bottom). Highlighted at RT=21.0 min is a m/z=411 peak that has a mass consistent with that of the 
dechlorinated NapT8 product. Highlighted at RT=22.5 min is a m/z=445 peak that corresponds to the NapT8 native 
product. At RT=19.0 min is a m/z=378 peak that correspond to the NapT8 native aromatic substrate 
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Figure 15. Proposed reaction scheme of NapT8 in DTT. In the absence of DTT, the NapT8 product with DMAPP is 
predominantly structure 2. In the presence of DTT, the product is a mixture of compounds with m/z values of 411 
with proposed structure 3.      
The observation that NapT8 catalytic activity is altered in DTT poses the question of whether 
this effect is specific to DTT or if the NapT8 known function is generally inhibited by reducing 
agents. The assays were modified to test NapT8 activity in the presence of other reducing agents 
tris(2-carboxyethyl)phosphine (TCEP) and glutathione (Figure 16). In each reaction, a peak 
appeared at m/z = 411 which is consistent with the product formed in the presence of DTT. Most 
notably, the dechlorinated product appeared in the assay incubated with 5 mM glutathione. 
Glutathione is a physiologically present reducing agent that exists at an intracellular 
concentration of 7 mM, which suggests that glutathione can drive this chemistry in the cell [12]. 
This suggests that the dechlorinated product is not just an unnatural by-product and that this kind 
of chemistry can possibly occur in vivo. This is not too surprising considering that analogues of 
napyradiomycins that are non-halogenated are produced by Streptomyces [3]. 
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Figure 16. NapT8 biochemical assays incubated in 5 mM of different reducing agents: DTT (top), Glutathione 
(middle), TCEP (bottom). In every assay, a peak at m/z=411 was observed at RT=21 min.  
In the reported biosynthetic pathway of the napyradiomycins, the NapT8 product 2 is quickly 
converted to the product 10 where the geranyl group at the C-4 position shifts to the C-3 position 
(Figure 17). It is suspected that the event of the NapT8 prenylation primes the C-3 position such 
that NapH3 can catalyze the prenyl group shift. As a result, we proposed that a dechlorination at 
the C-2 position would have adverse effects on the biosynthesis of napyradiomycin. In the 
following set of activity assays, a NapT8 and NapH3 coupled reaction was incubated with 
varying concentrations of DTT. 
 
Figure 17. NapT8 and NapH3 coupled synthetic scheme 
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Figure 18. NapT8 and NapH3 Coupled Assays in varying concentrations of DTT. 
In the absence of DTT, compounds 2 and 10 form, which is consistent with previously reported 
findings of the NapT8 and NapH3 coupled reactions (Figure 18) [4]. At a concentration of 0.5 
mM DTT, the compounds 2 and 10 form, along with the peak with m/z=411. This suggests that 
at trace amounts of DTT, the known functions of NapT8 and NapH3 are still dominant however, 
an unknown side-product forms that is consistently observed in the other DTT experiments. At a 
concentration of 5 mM DTT, the known activity of the NapT8 and NapH3 is significantly 
impacted. Product 10 is formed at a lower concentration and compound 2 is not present at all. 
Additionally, the side-product is formed in large excess (Figure 18).  
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This data suggests that initially, the NapT8 and NapH3 coupled reaction occurred to generate the 
NapH3 product, but the formation of the side-product quickly consumes the NapT8 product such 
that it cannot be consumed by NapH3. This data supports that the presence of the chlorine is 
required for NapH3 activity. 
It has been reported that NapT8 product 2 is enzymatically converted to compound 10 by 
NapH3, an enzyme next to NapT8 in the biosynthetic pathway of the napyradiomycins (Figure 
17) [4]. However, it has also been observed that this alpha-ketone rearrangement can occur 
spontaneously [4]. Since NapH3 catalyzes a reaction that can occur spontaneously, the 
expression of NapH3 in the napyradiomycin pathway seems to be redundant. Previously it was 
suggested that NapH3 exists primarily to speed up this alpha-ketone arrangement to the more 
chemically stable product 10. These findings suggests that the role of NapH3 is more significant 
than previously thought.  
Biochemical Assays with NapT8 and synthetic substrates 
NapT8 is reportedly selective for its prenyl substrates, although some PTases have been reported 
to exhibit promiscuity when it comes to accepting prenyl substrates. The selectivity of NapT8 
was investigated with synthetic prenyl pyrophosphate analogs propargyl, allyl, 2-butyne, and 
crotyl pyrophosphates which we synthesized by Dr. Shaun McKinnie. The proposed products are 
shown in Figure 19. These synthetic prenyl groups were synthesized based on the location of -
bonds with respect to the diphosphate group. Additionally, based on the substrate specificity 
NapT8 has for DMAPP, the prenyl groups were kept at a chain length of three to four carbons.  
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Figure 19. Predicted products from NapT8 assay with synthetic prenyl substrates. The products prenylated with 
crotyl pyrophosphate 6, allyl pyrophosphate 7, propargyl pyrophosphate 8, and 2-butyne pyrophosphate 9 have 
expected m/z values of 431, 417, 415, and 429, respectively. Peaks with m/z values consistent with compounds 7, 8, 
and 9 were not observed (Fig.10 rows 2-4). A strong peak at m/z= 431 was observed (Fig.10 bottom row) that is 
consistent with the proposed structure 6. 
Not surprisingly, no prenylated product was observed for the NapT8 assay with the alkyne 
pyrophosphates (Figure 20). This could potentially be a result of the stability of the triple bond, 
which makes it difficult for the -electrons to resonate to the phosphorylated carbon. Similarly, 
the assay with the allyl pyrophosphate yielded no prenylated product (Figure 20). However, the 
assay with the crotyl pyrophosphate produced a peak with a m/z value that is consistent with the 
exact mass of the proposed crotylated NapT8 substrate. This suggests that NapT8 accepted the 
crotyl pyrophosphate.  
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Figure 20. NapT8 assays incubated with different synthetic prenyl groups. No observable products were observed 
with propargyl, 2-butyne, or allyl pyrophosphate. The NapT8 assay with substrate crotyl produced a peak with m/z= 
431 which is consistent with the mass of the expected crotylated product.  
Although NapT8 did seem to accept the synthetic crotyl pyrophosphate, this is not too surprising 
considering that the crotyl group differs from the dimethylallyl group by the absence of only one 
methyl group. Furthermore, NapT8 did not seem to accept the allyl group even though it only 
differs from the dimethylallyl group by the absence of two methyl groups. The results of these 
activity assays with synthetic substrates highlights the remarkable substrate specificity of NapT8. 
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4. Investigation of prenyltransferase activity of CnqP3 and CnqP4 
It was hypothesized that FPP was the prenyl substrate for CnqP3 and/or CnqP4. Both CnqP3 and 
CnqP4 were tested for activity with THN as the aromatic substrate and FPP as the prenyl 
substrate. Upon comparison with the enzyme-free negative control assay, analysis by LCMS 
suggests that there was no observable product formation with these reaction conditions (Figure 
21). This suggests that both CnqP3 and CnqP4 do not accept FPP as their prenyl substrate or 
THN as their aromatic substrate. 
 
Figure 211. Activity assays with FPP as the prenyl donor by LCMS. No products were observed. 
ABBA PTases are known to have high selectivity for their prenyl substrate [1], so CnqP3 and 
CnqP4 for tested for activity with other physiologically present pyrophosphates GPP and 
DMAPP. Interestingly, both activity assays with GPP in the presence of CnqP3 and in the 
presence of CnqP4 seemed to exhibit a product formation (Figure 22). However, the products 
observed were not consistent with the products that were expected. The CnqP3 assay with GPP 
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produced two peaks at m/z=343 and m/z=341. The CnqP4 assay with GPP also produced a peak 
at m/z=343 with the same retention time as that of the 343 peak in the CnqP3 assay.  
 
Figure 22. Activity assays with GPP as the prenyl donor. The peak at RT= 13.5 min has a m/z value of 204 which 
corresponds to flaviolin (oxidized form of THN). A product was observed at m/z=343 and m/z=341 in the CnqP3 
assay. Similarly, products were observed at m/z=343 in the CnqP4 assay. 
The expected product by an ABBA PTase is a geranylated THN (Figure 23a). However, it seems 
like the m/z=343 peak is consistent with the oxidized form of gernaylated THN (Figure 23b) and 
the m/z=341 peak is consistent with a geranylated flaviolin (Figure 23c). These results are not 
too surprising given that THN is unstable and it is easily oxidized to flaviolin by atmospheric 
oxygen. As a result, oxidized analogs of a prenylated THN compound can be expected. 
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Figure 23. Proposed products from activity assay with GPP. (a) Proposed geranylated THN (b) Proposed 
geranylated THN followed by subsequent oxidation (c) Proposed geranylated flaviolin (oxidized THN) product. It is 
equally possible that the prenylation pattern can occur at the C-4 position 
The results of the activity assays with GPP are consistent with what has been previously 
reported. A previous study by Leipoldt et al reported that CnqP3 is capable of producing 
geranylated flaviolin [4]. Additionally, it has been reported that CnqP3 is capable of geranylating 
several analogs of dihydroxynaphthalene (DHN) including 1,6-DHN and 2,7-DHN [4]. CnqP4 
has also been reported to produce a geranylated product with 2,7-DHN [4].  
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Figure 24. Activity assay with DMAPP as the prenyl donor. No products were observed here. The peak at RT= 13.5 
min has a m/z value of 204 which corresponds to flaviolin (oxidized form of THN). The chromatogram for the 
CnqP3 reaction seems to be different from the negative control but it has a m/z value consistent with the mass for 
the flaviolin. The shift in retention time could be potentially be due to a leak in the LCMS during sample loading. 
CnqP3 and CnqP4 were also tested for activity with THN as the aromatic substrate and DMAPP 
as the prenyl substrate. Upon comparison with the enzyme-free negative control assay, analysis 
by LCMS suggests that there was no observable product formation with these reaction conditions 
(Figure 24). This is not surprising given that CnqP4 has not been reported to form a product 
when incubated with DMAPP and DHN analogs 1,3-DHN, 2,7-DHN, or 1,6-DHN [4]. Results 
for the activity assays with CnqP3 was slightly surprising because CnqP3 has been reported to 
form a product when incubated with DMAPP and 1,6-DHN [4].  
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CONCLUSIONS 
The ABBA PTases studied in this project consistently showed remarkable selectivity with 
respect to their prenyl substrates.  
Attempts to modify NapT8 substrate specificity proved to be challenging because of its high 
selectivity towards its native prenyl substrate DMAPP. It has been confirmed that NapT8 does 
not accept GPP or FPP under previously reported assay conditions where DMAPP is accepted 
[4]. Based on the homology model, the R58 in NapT8 was suggested to sterically hinder GPP 
from entering the NapT8 active site pocket, only allowing for DMAPP. However, production of 
the NapT8 known product in the R58S mutant was significantly diminished. This suggests that 
R58 of NapT8 is important for more than just selecting the length of the prenyl donor.  
As mentioned previously, NapT8 is only one of a suite of enzymes in the napyradiomycin 
pathway. NapH3 is an enzyme reported to catalyze an α-hydroxyketone rearrangement following 
the prenylation of the NapT8 aromatic substrate [3]. However, the rearranged NapT8 product has 
been observed to occur spontaneously even in the absence of NapH3 which poses the question of 
why an organism requires such an enzyme as NapH3 in the first place. The observation of 
dechlorinated products that form in the presence of glutathione, a physiologically present 
reducing agent, suggests that the role of NapH3 is not redundant but rather a mechanism that 
controls undesirable side products. 
To further expand the possible products of NapT8, we used a series of unnatural DMAPP 
derivatives. We found that NapT8 accepts only the crotyl pyrophosphate derivate indicating that 
NapT8 has some capacity to catalyze prenylation with other synthetic prenyl groups. Moving 
forward, analogs of the unnatural crotyl pyrophosphate such as a cis-crotyl pyrophosphate or a 2-
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pentene pyrophosphate can be tested for reactivity. To be sure that NapT8 can indeed prenylate 
at the C-2 position with crotyl pyrophosphate, the activity assay would need to be conducted on a 
larger scale and structural characterization by NMR would need to be investigated. 
The specific function of CnqP3 and CnqP4 is still largely unknown. There are no observable 
products when CnqP4 is incubated with their potential substrates THN and FPP. Similarly 
CnqP3 yields no observable products when incubated with THN and similar prenyl substrates. 
These results suggest that CnqP3 and CnqP4 may not have roles in the biosynthetic pathway of 
the marinones or neomarinone pathways as previously anticipated. As reinforced by this study, 
they exhibit promiscuity when incubated with analogs of the supposed aromatic substrate and 
prenyl substrates which makes their specificity challenging to determine [4]. Thus, identifying 
the biosynthetic pathway to which CnqP3 and CnqP4 belong to is still unknown. 
Although the active site of NapT8 has yet to be determined, we were able to expand the activity 
of NapT8 in the presence of reducing agent and unnatural prenyl group derivatives. These results 
can pave way for generating novel napyradiomycin analogs with potentially novel bioactivity.  
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APPENDIX 
A1. FPLC traces and protein gels 
Key: L - ladder, S - supernatant, FT - flowthrough, W - wash, F1…F14 - Fraction 1…Fraction 
14, UP - unpurified, C - cut, UC - uncut 
A1.1 Purification of NapT8 by nickel chromatography 
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Purification of NapT8 by cleaving poly-His tag 
 
Purification of NapT8 by size-exclusion chromatography 
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A1.2. Purification of NapT9 by Nickel column chromatography 
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Purification of NapT9 by cleaving the TEV tag 
 
Purification of NapT9 by size-exclusion chromatography 
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A1.3. Purification of Mcl23 by nickel column chromatography 
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Purification of Mcl23 by size-exclusion chromatography 
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A1.4. Purification of CnqP3 by nickel column chromatography 
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A1.5. Purification of CnqP4 by Nickel column chromatography 
 
 
A2. Prenyl group analogs used as inhibitors for protein crystallization trials 
 
Dimethylallyl thiolodiphosphate (DMASPP) is an inactive analog of DMAPP. Geranyl 
thiolodiphosphate is an inactive analog of GPP. 
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A3. NMR of FPP. 
HNMR of FPP 
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COSY NMR of FPP 
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A4. Sequencing Data NapT8 R58S mutation. The R58S mutant is the query sequence. The 
native NapT8 sequence is the subject sequence. Alignment with sequence results in the forward 
direction (top) confirms a R to S mutation. Alignment with sequence results in the reverse 
direction (bottom) also confirms a R to S mutation.   
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